← Leaderboards
Debbie S Gipson
University Of Washington
$9,175,721
Attributed
$17,758,299
Total exposure
24
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$16,358,499 · 23
FDA$1,399,800 · 1
By mechanism
UM1$6,362,239 · 1
U24$4,584,168 · 1
U01$2,624,596 · 1
U54$2,423,118 · 2
UG3$1,399,800 · 1
R56$270,746 · 1
Top collaborators
- Bruce Marshall Robinson17 shared
- Matthias Kretzler16 shared
- Brenda W Gillespie7 shared
- John Devin Peipert2 shared
- Jennifer J. Gassman1 shared
- Frederick Kaskel1 shared
- Laura H Mariani1 shared
- Howard Trachtman1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Trevor Cohen$7,813,751
- Lucas R. Hoffman$5,810,954
- Anthony J Rossini$1,403,784
- Bryan R Kestenbaum$15,927,099
- Stephen L Seliger$5,105,339
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelAncillary StudyRenal Glomerular DiseaseFocal Segmental GlomerulosclerosisResourcesChildProteinuriaDiagnosisCohortEnd Stage Renal FailureKidneyClinical TrialsResponseChildhoodBaseAdultCommunitiesKidney DiseasesProspectivePathway InteractionsRenal FunctionEnsureResearch DesignCharacteristics
Grant awards (53)
Study B- cNEPTUNE$461,969
U54 · FY2023 · DK · contact PI
Preparing a clinical outcomes assessment set for nephrotic syndrome [Prepare-NS]$724,783
UG3 · FY2022 · FD · contact PI
Study B- cNEPTUNE$536,324
U54 · FY2022 · DK · contact PI
CureGN$1,213,874
U24 · FY2021 · DK
Preparing a clinical outcomes assessment set for nephrotic syndrome [Prepare-NS]$675,017
UG3 · FY2021 · FD · contact PI
Study B- cNEPTUNE$536,324
U54 · FY2021 · DK · contact PI
CureGN$150,000
U24 · FY2021 · DK
CureGN$140,000
U24 · FY2021 · DK
CureGN$109,575
U24 · FY2021 · DK
CureGN$1,214,809
U24 · FY2020 · DK
Study B- cNEPTUNE$541,368
U54 · FY2020 · DK · contact PI
CureGN$237,601
U24 · FY2020 · DK
CureGN$1,518,309
U24 · FY2019 · DK
Study B- cNEPTUNE$347,133
U54 · FY2019 · DK · contact PI
GDPrime$815,500
UM1 · FY2018 · DK
GDPrime$115,000
UM1 · FY2018 · DK
GDPrime$907,095
UM1 · FY2017 · DK
GDPrime$907,094
UM1 · FY2016 · DK
GDPrime$907,095
UM1 · FY2015 · DK
GDPrime$300,000
UM1 · FY2015 · DK
GDPrime$113,379
UM1 · FY2015 · DK
GDPrime$908,275
UM1 · FY2014 · DK
GDPrime$686,466
UM1 · FY2014 · DK
GDPrime$702,335
UM1 · FY2013 · DK
FSGS Cohort Study$270,746
R56 · FY2010 · DK
Multicenter Trial of Focal Glomerulosclerosis$221,250
U01 · FY2009 · DK · contact PI
Multicenter Trial of Focal Glomerulosclerosis$50,000
U01 · FY2008 · DK · contact PI
NOVEL THERAPY FOR RESISTANT FSGS$8,800
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: FOCAL SEGMENTAL GLOMERULOSCLEROSIS CLINICAL TRIAL$4,821
M01 · FY2008 · RR · contact PI
CHRONIC KIDNEY DISEASE IN CHILDREN$1,607
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: MYCOPHENOLATE MOFETIL IN PATIENTS WITH 1GA NEPHROPATHY$536
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: GC1008 IN PATIENTS WITH TREATMENT RESISTANT IDIOPATHIC FSGS$76
M01 · FY2008 · RR · contact PI
Multicenter Trial of Focal Glomerulosclerosis$388,401
U01 · FY2007 · DK · contact PI
FOCAL SEGMENTAL GLOMERULOSCLEROSIS CLINICAL TRIAL$14,631
M01 · FY2007 · RR · contact PI
NOVEL THERAPY FOR RESISTANT FSGS$9,004
M01 · FY2007 · RR · contact PI
CHRONIC KIDNEY DISEASE IN CHILDREN$3,376
M01 · FY2007 · RR · contact PI
EVALUATION OF THE ASSOCIATION OF COGNITIVE FUNCTION AND CHRONIC KIDNEY DISEASE$1,313
M01 · FY2007 · RR · contact PI
MYCOPHENOLATE MOFETIL IN PATIENTS WITH 1GA NEPHROPATHY$938
M01 · FY2007 · RR · contact PI
Multicenter Trial of Focal Glomerulosclerosis$400,000
U01 · FY2006 · DK · contact PI
FOCAL SEGMENTAL GLOMERULOSCLEROSIS CLINICAL TRIAL$11,894
M01 · FY2006 · RR · contact PI
EVALUATION OF THE ASSOCIATION OF COGNITIVE FUNCTION AND CHRONIC KIDNEY DISEASE$10,160
M01 · FY2006 · RR · contact PI
MYCOPHENOLATE MOFETIL IN PATIENTS WITH 1GA NEPHROPATHY$2,478
M01 · FY2006 · RR · contact PI
CHRONIC KIDNEY DISEASE IN CHILDREN$248
M01 · FY2006 · RR · contact PI
Multicenter Trial of Focal Glomerulosclerosis$388,598
U01 · FY2005 · DK
EVALUATION OF THE ASSOCIATION OF COGNITIVE FUNCTION AND CHRONIC KIDNEY DISEASE$12,252
M01 · FY2005 · RR
MYCOPHENOLATE MOFETIL IN PATIENTS WITH 1GA NEPHROPATHY$3,456
M01 · FY2005 · RR
FOCAL SEGMENTAL GLOMERULOSCLEROSIS CLINICAL TRIAL$314
M01 · FY2005 · RR
Multicenter Trial of Focal Glomerulosclerosis$285,434
U01 · FY2004 · DK
Multicenter Trial of Focal Glomerulosclerosis$615,289
U01 · FY2003 · DK
Multicenter Trial of Focal Glomerulosclerosis$75,624
U01 · FY2003 · DK
Multicenter Trial of Focal Glomerulosclerosis$200,000
U01 · FY2002 · DK
DIALYSIS ADEQUACY IN CHILDREN ON PERITONEAL DIALYSIS$3,864
M01 · FY2000 · RR
DIALYSIS ADEQUACY IN CHILDREN ON PERITONEAL DIALYSIS$3,864
M01 · FY2000 · RR